Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d5af24bfbb650ae2e7ddf95747271e81 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05 |
filingDate |
2009-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48bbc0fa639a83f38d468b67a48da4b2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30a9fb8760e4133f526504d5254b6488 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_449038a701df85ca68b6b05afdd15a15 |
publicationDate |
2010-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2249806-A2 |
titleOfInvention |
Resveratrol formulations |
abstract |
Resveratrol can be used to treat or inhibit the onset of many diseases that are related to the aging process, but large doses are required. The present invention provides concentrated liquid formulations of resveratrol, typically having a resveratrol concentration of at least 10% by weight. These formulations improve patient compliance because the patient need not consume such a large volume of a resveratrol formulation. |
priorityDate |
2008-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |